OPB-101

· Outpace Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OPB-101, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer [Phase 1]